This HTML5 document contains 96 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q79236016
rdf:type
wikibase:Item
schema:description
scientific article published on 13 October 2006 наукова стаття, опублікована в жовтні 2006 artículu científicu espublizáu n'ochobre de 2006 im Oktober 2006 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q79236016-4FF9B3EA-5D32-468C-AEDE-C63B0F42B416
wdt:P577
2006-10-13T00:00:00Z
p:P2888
wds:Q79236016-7EAD6AD3-36CB-42FC-A058-E8BFACDD1C88
wdt:P2888
n13:s10637-006-9012-9
p:P2860
wds:Q79236016-88FE7A54-5F3D-4EC0-B06C-8C96B026694A wds:Q79236016-8E5B2677-F2FE-4F88-BC1B-899BCD733D93 wds:Q79236016-936DD82B-E2D8-43D0-A3D2-FCC5CDA8E8AC wds:Q79236016-6D1062C2-5CA6-4F70-834E-41AF73434F3D wds:Q79236016-17282B93-01B4-4773-A249-7D32CC352794 wds:Q79236016-1D7F92C1-6C67-49C5-ADF9-6B5C9B03ECBD wds:Q79236016-31FCEC19-2E98-48EA-84AB-FDBF560BEA84 wds:Q79236016-C47AB3F1-FA65-4E09-9464-49B92D1F6BE8 wds:Q79236016-BD3DED57-FDCC-47D2-BE9D-33BC2F6C3660 wds:Q79236016-AAD8B1D8-DD49-4AB4-A4CE-0B30E5BA6116 wds:Q79236016-A10E5F44-41B5-40A1-A08F-F4BCFB7B4B54 wds:Q79236016-A5AD0506-65B4-4D59-968C-5604728A4307 wds:Q79236016-0FB4F97A-4115-489D-A0EE-83E0E73AA464 wds:Q79236016-15A70C18-BC52-4157-8EE5-CEB3DA3E2D6F wds:Q79236016-FC9BECEF-33FA-4D98-9A33-92E04F66D562 wds:Q79236016-F4A62BB6-3494-44AD-85DD-8EE6E5BF9371
wdt:P2860
wd:Q42537725 wd:Q42007942 wd:Q55234480 wd:Q55241271 wd:Q43850218 wd:Q51551095 wd:Q35225432 wd:Q33489695 wd:Q71261842 wd:Q78103596 wd:Q40990202 wd:Q41452739 wd:Q72426675 wd:Q67492629 wd:Q55021320 wd:Q55003539
p:P2093
wds:Q79236016-049E0E42-F232-4C13-883A-0DD7F1860C0C wds:Q79236016-C1551D09-A898-4CBB-8675-5A44C25FAEB0 wds:Q79236016-A46C2A5F-5493-449D-9AA2-AF2E90966DB6 wds:Q79236016-AB3B90BB-989E-4CAA-9619-7686D6536A31 wds:Q79236016-A864805A-190D-4913-A5BC-9F73249B216F wds:Q79236016-7F3E6974-A584-43A9-9E12-92A4B38902B3 wds:Q79236016-645720D7-85B9-480D-8190-D91B5F35877D wds:Q79236016-9CE4996D-B1E9-4200-9B94-B3FF8B7BE75E wds:Q79236016-3726272C-2409-48C0-9E44-4B844B17DBC2 wds:Q79236016-4F7F4321-0A07-41DE-A171-819E7377CBFE wds:Q79236016-EA684B95-1919-4662-87CC-9E2505690BC1 wds:Q79236016-F2FAEDBB-97D6-4115-AD94-7C061038F31C
wdt:P2093
Nobuyuki Katakami Masaaki Kawahara Masahiro Fukuoka Shunichi Negoro Takashi Yana Yutaka Ariyoshi Soichiro Yokota Hidehiko Yamamoto Yoshiki Takada Takahiko Sugiura West Japan Thoracic Oncology Group Minoru Takada
rdfs:label
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
skos:prefLabel
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
schema:name
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
p:P50
wds:Q79236016-BBCD8D3D-2E7C-4FDA-AC3C-20772B7BF61C
wdt:P50
wd:Q56697654
p:P1476
wds:Q79236016-C99A9F5B-D93E-4510-BB2E-4E8FD4C508FA
wdt:P1476
Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
p:P304
wds:Q79236016-271FF9B6-B8E5-4714-94D1-43DF6AEF416A
wdt:P304
253-258
p:P31
wds:Q79236016-60C64E93-DC95-4D16-8E88-C5CD22351641
wdt:P31
wd:Q13442814
p:P921
wds:Q79236016-F9B67118-5C36-47F7-8A0D-63045C6E6268
wdt:P921
wd:Q47912
p:P698
wds:Q79236016-C6858168-98B3-474A-8AB4-077BD6662668
wdtn:P698
n11:17039404
wdt:P698
17039404
p:P1433
wds:Q79236016-E982FC29-A41E-4E44-B1E6-8BF318D1F7A8
wdt:P1433
wd:Q2312231
p:P433
wds:Q79236016-AF6EF700-B2EB-414C-A570-A04CDA887648
p:P478
wds:Q79236016-B799AECC-AE68-446F-A7A9-2EAB3356933E
wdt:P433
3
wdt:P478
25
p:P356
wds:Q79236016-A103632D-0C3A-4785-8B6A-D565BC568F02
wdtn:P356
n12:S10637-006-9012-9
wdt:P356
10.1007/S10637-006-9012-9
p:P6179
wds:Q79236016-08E8E155-6581-46AA-BB43-5855DCEF01DD
wdt:P6179
1003166376